TaherBashirAbu HejlehMD

Assistant Professor, Internal Medicine, University of Iowa College of Medicine

Dr. Abu Hejleh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-2075

Fax+1 319-353-8383

University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2006 - 2009
Jordan University of Science and Technology FOMClass of 2004

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy Start of enrollment: 2019 Apr 15
Terminated
Roles: Sponsor-Investigator, Principal Investigator, Contact

PubMed

2 citations
Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer.
P Abena Anyidoho, Claire F Verschraegen, Merry Jennifer Markham, Steven Alberts, John Sweetenham
JCO Oncology Practice. 2023-05-01
2 citations
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: ...
Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, Lawrence Eric Feldman, Taher Abu Hejleh
Clinical Lung Cancer. 2022-11-01
5 citations
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer.
Matthew G Field, H Culver Boldt, Taher Abu Hejleh, Elaine M Binkley
American Journal of Ophthalmology Case Reports. 2022-06-01